Browsing: Bio Tech & Pharma
The recent approval of TEPEZZA in Asia signifies a major step forward in the global treatment of Thyroid Eye Disease…
“The breadth of these data showcases our strategy to advance diverse modalities for difficult-to-treat cancers,” stated Jay Bradner, M.D., executive…
At Amgen, Dr. Jay Bradner, the Executive Vice President of Research and Development and Chief Scientific Officer, emphasized the strategic…
Cardiol Therapeutics is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies…
Amgen (NASDAQ:AMGN) recently shared new data on IMDELLTRA TM (tarlatamab-dlle), a novel delta-like ligand 3 (DLL3)-targeting Bispecific T-cell Engager (BiTE…
Amgen, a leading biotechnology company (NASDAQ: AMGN), has announced the presentation of new data on IMDELLTRA TM, a first-in-class delta-like…
Cardiol Therapeutics is a clinical-stage life sciences company focused on researching and developing anti-inflammatory and anti-fibrotic therapies for heart disease…
Apple introduced innovative features focused on sleep and hearing health for Apple Watch and AirPods Pro 2, aligning with the…
The positive tumour response observed in the sixth patient has resulted in the initiation of additional recruitment for the ongoing…
The FDA has granted Fast Track Designation to Narmafotinib for the treatment of advanced pancreatic cancer. This designation is intended…